Thyroid cancer drug gets PBS listing

Thyroid cancer patients spending more than $100,000 a year on treatment will be able to access it for $38 thanks to a federal government subsidy.

Health Minister Sussan Ley says the listing of cancer drug lenvatinib (Lenvima) on the Pharmaceutical Benefits Scheme from Thursday will help about 140 Australians who currently pay more than $117,000 for one year of treatment.

They'll now be able to get it for $38.30, or $6.20 for concessional patients.

Latest

Trending